University of Pittsburgh Health Sciences eLearning Environment Internet-based Studies in Education and Research
INTRODUCTION
4/16/2019 - Medical Grand Rounds: Bench to Bedside- Bacteriophage Therapy for Multidrug Resistant Bacterial Infections: Back to the Future
QUIZ
EVALUATION
CERTIFICATE
Credit Hours: CME 1.00
Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.
Upon completion of this activity, participants should be able to:
- Describe the biological properties of bacteriophages.
- Recognize the global challenges posed by multidrug resistant bacterial infections.
- Describe the biology and potential therapeutic potential of bacteriophages.
Schooley RT, Biswas B, Gill JJ, Hernandez-Morales A, Lancaster J, Lessor L, Barr JJ, Reed SL, Rohwer F, Benler S, Segall AM, Taplitz R, Smith DM, Kerr K, Kumaraswamy M, Nizet V, Lin L, McCauley MD, Strathdee SA, Benson CA, Pope RK, Leroux BM, Picel AC, Mateczun AJ, Cilwa KE, Regeimbal JM, Estrella LA, Wolfe DM, Henry MS, Quinones J, Salka S, Bishop-Lilly KA, Young R, Hamilton T. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a disseminated resistant Acinetobacter baumannii infection. Antimicrob Agents Chemother. 2017 Aug 14. pii: AAC.00954-17. doi: 10.1128/AAC.00954-17. PMC5610518
No relationships with industry relevant to the content of this educational activity have been disclosed.
Dr. Schooley receives grant/research support from Gilead Sciences, Monogram Biosciences. He is a consultant with CytoDyn and a Stockholder with Antiva Biosciences.
This activity is approved for AMA PRA Category 1 Creditâ„¢
The University of Pittsburgh is an affirmative action, equal opportunity institution.